InvestSMART

Genetic Technologies Limited (ASX: GTG) - Announcements

DELISTED - Current share price for GTG : $0.039

ASX company news and announcements for Genetic Technologies Limited (GTG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Technologies Limited (GTG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Technologies Limited (GTG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Technologies Limited (GTG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 Lodgement of Prospectus - Non-renounceable Entitlement Offer 2 Aug 2024 9:39AM $0.042 $0.039 fallen by 7.14%
$52 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2024 12:58PM $0.044 $0.039 fallen by 11.36%
$52 Proposed issue of securities - GTG 26 Jul 2024 9:20AM $0.041 $0.039 fallen by 4.88%
$52 Strategic restructure to focus on USA sales growth 26 Jul 2024 9:19AM $0.041 $0.039 fallen by 4.88%
$52 Change in substantial holding 19 Jul 2024 8:18AM $0.050 $0.039 fallen by 22%
$52 Change in substantial holding 18 Jul 2024 8:27AM $0.051 $0.039 fallen by 23.53%
$52 S708A Cleansing Notice 16 Jul 2024 2:35PM $0.049 $0.039 fallen by 20.41%
$52 Application for quotation of securities - GTG 16 Jul 2024 2:21PM $0.049 $0.039 fallen by 20.41%
$52 Appointment of CFO and Company Secretary 16 Jul 2024 11:56AM $0.051 $0.039 fallen by 23.53%
$52 Change in substantial holding 12 Jul 2024 8:24AM $0.068 $0.039 fallen by 42.65%
$52 GeneType to Enter Canadian and New Zealand Markets 9 Jul 2024 9:34AM $0.071 $0.039 fallen by 45.07%
$52 Resignation of CFO and Company Secretary 28 Jun 2024 5:00PM $0.075 $0.039 fallen by 48%
$52 Business Update - June 2024 28 Jun 2024 8:20AM $0.079 $0.039 fallen by 50.63%
$52 GeneType identifies 79.5% at risk of serious disease 25 Jun 2024 9:43AM $0.083 $0.039 fallen by 53.01%
$52 Change in substantial holding 24 Jun 2024 8:11AM $0.092 $0.039 fallen by 57.61%
$52 GTG Live Investor Webinar and Q&A - June 27 21 Jun 2024 8:43AM $0.087 $0.039 fallen by 55.17%
$52 GTG Expands Operational Capacity in North America 18 Jun 2024 9:31AM $0.098 $0.039 fallen by 60.20%
$52 Notification regarding unquoted securities - GTG 12 Jun 2024 1:53PM $0.097 $0.039 fallen by 59.79%
$52 GeneType and Stayhealthy Announce Landmark Distribution Agre 5 Jun 2024 2:44PM $0.100 $0.039 fallen by 61%
$52 Change in substantial holding 5 Jun 2024 8:24AM $0.100 $0.039 fallen by 61%
$52 Launch of test for 100% risk of breast and ovarian cancer 29 May 2024 9:32AM $0.110 $0.039 fallen by 64.55%
$52 Form F-1 Registration Statement 20 May 2024 10:20AM $0.125 $0.039 fallen by 68.80%
$52 GTG and Wellworks for You sign B2B sales and marketing deal 6 May 2024 9:49AM $0.120 $0.039 fallen by 67.50%
$52 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 9:43AM $0.115 $0.039 fallen by 66.09%
$52 Change in substantial holding 24 Apr 2024 8:21AM $0.125 $0.039 fallen by 68.80%

101 - 125 of 896 results

Page 5 of 36

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.